Variable | AMR (n = 28) | Ctrl (n = 32) | P value |
---|---|---|---|
Age, years | 33.29 ± 7.154 | 37.31 ± 8.525 | NS |
Male gender, n (%) | 25 (89%) | 26 (81%) | NS |
BMI | 21.8 (19.7, 25.53) | 23.3 (21.1, 24.95) | NS |
Cr, μmol/L | 285 (218.3, 417.3) | 93.5 (75.25, 100.8) | < 0.0001 |
BUN, mmol/L | 16.6 (12.35, 19.4) | 6.625 (5.628, 7.413) | < 0.0001 |
UA, μmol/L | 398.5 (316.3, 458.8) | 337.5 (301, 370) | 0.0198 |
CO2, mmol/L | 21 (18.25, 23) | 23.4 (22.05, 25) | 0.0019 |
CysC, mg/L | 3.49 (2.78, 4.25) | 1.085 (0.975, 1.36) | < 0.0001 |
ALB, g/L | 37.8 (36.15, 39.63) | 39.63 (41.45, 48.28) | < 0.0001 |
TBA, μmol/L | 2.75 (2.125, 5.975) | 4.65 (3.4, 6.85) | 0.0257 |
LDH, U/L | 248.5 (186.8, 327.5) | 221 (173.8, 277.5) | NS |
ALP, U/L | 96 (59.25, 134.3) | 77 (70.25, 101) | NS |
HGB, g/L | 95 (86, 105.5) | 139.5 (126.3, 152.5) | < 0.0001 |
WBC, × 109/L | 4.28 (3.523, 6.5) | 5.55 (5.01, 6.793) | 0.0091 |
PLT, × 109/L | 172 (116.3, 232) | 193 (140, 225.8) | NS |
CRP, mg/L | 1.9 (1.15, 9.41) | 0.79 (0.5, 1.755) | 0.0005 |
U-protein, −/±/+/++/+++ | 0/0/5/9/14 | 24/4/3/1/0 | < 0.0001 |
Induction therapy, Thymoglobuline, n (%) | 28 (100%) | 32 (100%) | NS |
Maintenance Therapy | Â | Â | Â |
Tacrolimus, n (%) | 28 (100%) | 32 (100%) | NS |
Mycophenolate mofetil, n (%) | 28 (100%) | 32 (100%) | NS |
Prednisone, n (%) | 28 (100%) | 32 (100%) | NS |